Tag: well

TSX: TVECALGARY, AB, June 16, 2026 /CNW/ - Tamarack Valley Energy Ltd. has successfully closed the previously announced sale of its Charlie Lake assets for...

Launching a resort-wide "Wing Lei Bar & Friends" Special Edition, Wynn will unite over 50 global mixology and culinary visionaries from July 24 to 29MACAO,...

Claret Capital Partners is providing growth funding of €43m as part of Inventiva’s €130m debt financing, to support its lead asset through Phase 3.

Elísa Dögg Moraitis Björnsdóttir has been appointed Executive Vice President of Eimskip’s Iceland Domestic Operations division. The division includes land transport and distribution centers, warehouse and cold store operations, as well as facility management. The division employs around 400 people across 16 locations nationwide.

New Tyvek® innovation designed to support worker safety and comfort across ASEANBANGKOK, June 16, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it...

BEIJING, June 16, 2026 /PRNewswire/ -- A report from China Daily ...

BENGALURU, India, June 16, 2026 /PRNewswire/ -- KBR (NYSE: KBR) launched its inaugural Innovation Studio, powered by Applied Computing, in Bengaluru, India, establishing a...

AS LHV Group’s May financial results reflected positive performance, with the results of all subsidiaries in line with the financial plan. LHV Group earned a consolidated net profit of EUR 9.1 million in May, with return on equity attributable to shareholders of 14.1%. Among the subsidiaries, AS LHV Pank earned EUR 9.8 million, LHV Bank Ltd EUR 0.3 million, AS LHV Varahaldus EUR 0.2 million and AS LHV Kindlustus EUR 0.4 million in net profit.

Handcrafted in San Francisco, the Gramercy Leather Sling offers a full-grain leather alternative to the technical fabric crossbody bags that dominate compact everyday carry....

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

KUALA LUMPUR, Malaysia, June 16, 2026 /PRNewswire/ -- Amaron, the flagship battery brand from Amara Raja Energy & Mobility Limited, is set to strengthen its...